Aspect Imaging greatly values its relationship with Mediso and under its current
commercial agreement, has placed significant resources and MR expertise to support
the M2 compact high-performance MRI system which is manufactured for and sold to
Mediso as a key component of its NanoScan PET/MRI and SPECT/MRI systems.
Aspect maintains a full development and support team at its headquarters in Shoham,
Israel that actively works on the M2 platform in the areas of:
With 80+ full-time staff, Aspect Imaging has extensive ongoing efforts on the M2
platform for pre-clinical, including the NanoScan-related products, clinical and
advanced industrial applications.
For more information about the
Mediso nanoScan® PM PET/MRI
or SPECT/MRI or to view an in vivo
demonstration at select luminary
sites, please contact: